Results 51 to 60 of about 8,790,513 (336)

Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma. [PDF]

PLoS ONE, 2016
BACKGROUND:Costly biologicals in palliative oncology are emerging at a rapid pace. For example, in patients with advanced esophageal squamous cell carcinoma addition of cetuximab to a palliative chemotherapy regimen appears to improve survival.
Vincent T Janmaat, Marco J Bruno, Suzanne Polinder, Sylvie Lorenzen, Florian Lordick, Maikel P Peppelenbosch, Manon C W Spaander   +6 more
doaj   +1 more source

Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura.

Blood, 2020
Acquired thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease characterized by thrombotic microangiopathy leading to end-organ damage. The standard of care (SOC) treatment is therapeutic plasma exchange (TPE) alongside immunomodulation
G. Goshua, P. Sinha, J. Hendrickson, C. Tormey, P. Bendapudi, A. Lee   +5 more
semanticscholar   +1 more source

Details of incremental cost-effectiveness ratio computation.

, 2013
Details of incremental cost-effectiveness ratio computation.
Cristiana Pascutto (464517), Alessandra Pompa (464519), Roberta Ciampichini (464520), Alessandro Corso (464514), Lara Pochintesta (464521), Silvia Mangiacavalli (464515), Federica Cocito (464516), Lorenzo G. Mantovani (414007), Virginia Valeria Ferretti (464518)   +8 more
core   +1 more source

Comparing the Effect of Semi‐Immersive Virtual Reality, Computerized Cognitive Training, and Traditional Rehabilitation on Cognitive Function in Multiple Sclerosis: A Randomized Clinical Trial

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio, Desiree Latella, Lilla Bonanno, Paulo Cezar Rocha dos Santos, Marcos Maldonado‐Díaz, Meir Plotnik, Rosaria De Luca, Angelo Quartarone, Rocco Salvatore Calabrò   +8 more
wiley   +1 more source

Cost‐Effectiveness of Arthroscopic Partial Meniscectomy and Physical Therapy for Degenerative Meniscal Tear

ACR Open Rheumatology, 2022
Objective We examined the cost‐effectiveness of treatment strategies for concomitant meniscal tear and knee osteoarthritis (OA) involving arthroscopic partial meniscectomy surgery and physical therapy (PT). Methods We used the Osteoarthritis Policy Model,
Emma E. Williams, Jeffrey N. Katz, Valia P. Leifer, Jamie E. Collins, Tuhina Neogi, Lisa G. Suter, Bruce Levy, Alexander Farid, Clare E. Safran‐Norton, A. David Paltiel, Elena Losina   +10 more
doaj   +1 more source

Cost-effectiveness of adding atezolizumab to first-line chemotherapy in patients with advanced triple-negative breast cancer

Therapeutic Advances in Medical Oncology, 2020
Background: The effectiveness of atezolizumab plus nab-paclitaxel for advanced triple-negative breast cancer (TNBC) has been demonstrated. We aimed to evaluate its cost-effectiveness on advanced TNBC from the US payer perspective. Methods: A Markov model
Bin Wu, F. Ma
semanticscholar   +1 more source

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau, Marie Bruguet, Irina Viakhireva‐Dovganyuk, François‐Mathias Merrien, Denis Marechal, Aurore Jourdain, Philippe Goas, Jordan Coris, Julien Asselineau, Maëlys Consigny, Gérald Le Gac, Serge Timsit   +11 more
wiley   +1 more source

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies

BMC Health Services Research, 2019
Background Diabetic macular oedema (DMO) may lead to visual loss and blindness. Several pharmacological treatments are available on the National Health Service (NHS) to United Kingdom patients affected by this condition, including intravitreal vascular ...
Michal Pochopien, Annette Beiderbeck, Phil McEwan, Richard Zur, Mondher Toumi, Samuel Aballéa   +5 more
doaj   +1 more source

Average Cost-Effectiveness Ratio with Censored Data

Journal of Biopharmaceutical Statistics, 2012
In cost-effectiveness analysis, interest could lie foremost in the incremental cost-effectiveness ratio (ICER), which is the ratio of the incremental cost to the incremental benefit of two competing interventions.
H. Bang, Hong-Wei Zhao
semanticscholar   +1 more source

Cost, effectiveness and incremental cost-effectiveness ratio (vs. current scenario) by using PPSV–23 only.

, 2015
*ICER: incremental cost-effectiveness ratio (¥/QALY gained). All ICERs were rounded to the nearest thousand.Cost, effectiveness and incremental cost-effectiveness ratio (vs. current scenario) by using PPSV–23 only.
Masahide Kondo (636725), Ichiro Okubo (804142), Shu-ling Hoshi (804141)   +2 more
core   +1 more source